August 14, 2019 – INVO Bioscience Files 10-Q for Second Quarter Fiscal Year 2019
July 29, 2019 – INVO Bioscience Files S-1/A and Exhibits
August 2019 – Data Bridge Market Research Global Fertility Services Market Report
“Global Fertility Services Market – Industry Trends and Forecast to 2026” is a professional and in-depth study on the current state of the global Fertility Services industry with a focus on the worldwide market.
INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for its Intravaginal Culture System, INVOcell®, today announced financial results for the second quarter of 2019, ended June 30, 2019.Details
INVO Bioscience Announces Recent Appointment of Pressly Ahammed as Director of International Business Development
INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for the first Intravaginal Culture System, INVOcell®, announced the recent appointment of Pressly Ahammed as INVO Bioscience’s new Director of International Business Development.Details